Celtaxsys
Atlanta
About Celtaxsys
Celtaxsys, is a biopharmaceutical company, engages in developing and testing drug compounds for treating cancer, and inflammatory and autoimmune diseases. Its technology manipulates immune cell migration as a treatment for cancer, inflammation, and organ/tissue rejection. The company's drug compounds are designed to block the protective mechanisms created by certain tumors to prevent attack by immune system cells.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $65.2M
- Funding stage: Late Stage Venture
- Last round: Grant (Mar 2019)
- Website: celtaxsys.com
- Phone: (404) 920-0702
Industries & Categories
Biopharma, Biotechnology, Health Care
Social Profiles
Canonical: https://fsome.com/organization/celtaxsys-192390 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.